ROGER KIRKWOOD: Open Payments
NPI 1063728764 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,996 in 95 payments from 12 companies in 2025. Trend: 2023 $1,498 · 2024 $621 · 2025 $2,996
Food & beverage: $1,886Travel & lodging: $1,079Education: $31
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 13 | $1,425 |
| Supernus Pharmaceuticals, Inc. | 30 | $287 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $265 |
| ABBVIE INC. | 10 | $177 |
| Otsuka America Pharmaceutical, Inc. | 4 | $165 |
| Collegium Pharmaceutical, Inc. | 3 | $156 |
| Alkermes, Inc. | 6 | $138 |
| E.R. Squibb & Sons, L.L.C. | 3 | $122 |
| Axsome Therapeutics, Inc. | 2 | $81 |
| Lundbeck LLC | 3 | $70 |
Products named: SPRAVATO, Qelbree, REXULTI, TRINTELLIX, VRAYLAR, Jornay PM, COBENFY, Auvelity.
Industry payments across KS — which companies pay providers there.
